Correlation Between Werewolf Therapeutics and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and Protalix Biotherapeutics, you can compare the effects of market volatilities on Werewolf Therapeutics and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Protalix Biotherapeutics.
Diversification Opportunities for Werewolf Therapeutics and Protalix Biotherapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Werewolf and Protalix is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and Protalix Biotherapeutics
Given the investment horizon of 90 days Werewolf Therapeutics is expected to generate 1.84 times more return on investment than Protalix Biotherapeutics. However, Werewolf Therapeutics is 1.84 times more volatile than Protalix Biotherapeutics. It trades about 0.03 of its potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.03 per unit of risk. If you would invest 205.00 in Werewolf Therapeutics on September 4, 2024 and sell it today you would lose (9.00) from holding Werewolf Therapeutics or give up 4.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Werewolf Therapeutics vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Werewolf Therapeutics |
| Protalix Biotherapeutics |
Werewolf Therapeutics and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Werewolf Therapeutics and Protalix Biotherapeutics
The main advantage of trading using opposite Werewolf Therapeutics and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Werewolf Therapeutics vs. Candel Therapeutics | Werewolf Therapeutics vs. Cingulate Warrants | Werewolf Therapeutics vs. Unicycive Therapeutics | Werewolf Therapeutics vs. Cardio Diagnostics Holdings |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |